Using Healthcare Benchmarks to Drive Strategic Medical and Pharmacy Cost Management
As healthcare costs continue to rise, Chief Medical Officers (CMOs) of health plans face increasing pressure to identify and implement effective cost management strategies while maintaining quality of care. Industry benchmarks serve as crucial tools in this endeavor, offering insights into opportunities for medical and pharmacy spend reduction. Here's how successful CMOs leverage these benchmarks to drive strategic decisions and meaningful outcomes.
Understanding Benchmark Analysis and PMPM Variance
Per member per month (PMPM) variance analysis against industry benchmarks (such as Optum's) provides CMOs with an initial compass for identifying areas of opportunity. When a health plan's PMPM costs significantly exceed benchmark averages in specific categories, it signals potential areas requiring intervention through new care management programs or utilization management strategies.
What is a "Well-Managed Benchmark"?
A well-managed benchmark represents cost and utilization metrics achieved by high-performing health plans that have successfully implemented effective medical management programs. These benchmarks typically sit at the 25th percentile of overall market performance, representing achievable targets for organizations committed to optimization.
Moving from Identification to Action
Deep Dive Analysis
When PMPM variance indicates higher-than-benchmark spending, CMOs must drill down into claims data to understand the root cause:
Claims Analysis:
Examine individual high-dollar claims
Identify claim groupings by service category
Analyze provider practice patterns
Review medication utilization trends
Root Cause Assessment:
Outlier Claims: Single catastrophic cases or unusual events
Systematic Trends: Consistent patterns indicating process or program gaps
Provider Network Issues: Contractual terms or practice pattern variations
Population Health Factors: Demographic or risk-adjusted variations
Implementation and Timeline Considerations
The Reality of Cost Curve Modification
One of the most critical aspects CMOs must consider is the time required to "bend the cost curve." Traditional wisdom suggests:
Short-term Programs (3-6 months):
Prior authorization modifications
Formulary changes
Care management program adjustments
Medium-term Programs (6-12 months):
New care management program implementation
Provider network optimization
Clinical pathway development
Long-term Programs (12-24+ months):
Population health initiatives
Value-based care program implementation
Complex care management program maturation
Keep reading with a 7-day free trial
Subscribe to Thoughts on Healthcare Markets and Technology to keep reading this post and get 7 days of free access to the full post archives.